Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Personality predicts time to remission and clinical status in hypochondriasis during a 6-year follow-up.

Greeven A, van Balkom AJ, Spinhoven P.

J Nerv Ment Dis. 2014 May;202(5):402-7. doi: 10.1097/NMD.0000000000000133.

PMID:
24727716
2.

Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.

Wu Z, Chen J, Yuan C, Hong W, Peng D, Zhang C, Cao L, Fang Y.

J Affect Disord. 2013 Sep 25;150(3):834-9. doi: 10.1016/j.jad.2013.03.012. Epub 2013 Apr 6.

PMID:
23570952
3.

Citalopram-associated gambling: a case report.

Cuomo I, Kotzalidis GD, Caccia F, Danese E, Manfredi G, Girardi P.

J Gambl Stud. 2014 Jun;30(2):467-73. doi: 10.1007/s10899-013-9360-2.

PMID:
23385394
4.

Successful treatment of olfactory reference syndrome with paroxetine.

Teraishi T, Takahashi T, Suda T, Hirano J, Ogawa T, Kuwahara T, Nomura S.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):E24. doi: 10.1176/appi.neuropsych.11020033. No abstract available.

PMID:
22450633
5.

Psychopathological dimensions of tinnitus and psychopharmacologic approaches in its treatment.

Belli H, Belli S, Oktay MF, Ural C.

Gen Hosp Psychiatry. 2012 May-Jun;34(3):282-9. doi: 10.1016/j.genhosppsych.2011.12.006. Epub 2012 Jan 27. Review.

PMID:
22285367
6.
7.

Effectiveness of milnacipran for a patient with pain disorder and long QT syndrome.

Ikawa M, Yamada K.

Clin Neuropharmacol. 2010 May;33(3):163-4. doi: 10.1097/WNF.0b013e3181d61528.

PMID:
20173629
8.

Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up.

Greeven A, van Balkom AJ, van der Leeden R, Merkelbach JW, van den Heuvel OA, Spinhoven P.

J Behav Ther Exp Psychiatry. 2009 Sep;40(3):487-96. doi: 10.1016/j.jbtep.2009.06.005. Epub 2009 Jun 28.

PMID:
19616195
9.

Sertraline in the treatment of panic disorder.

Hobgood CD, Clayton AH.

Drugs Today (Barc). 2009 May;45(5):351-61. doi: 10.1358/dot.2009.45.5.1362066. Review.

PMID:
19584964
10.

[Indications for crenotherapy].

Dubois O.

Encephale. 2009 Jun;35 Suppl 4:S133-6. doi: 10.1016/S0013-7006(09)74524-5. Review. French. No abstract available.

PMID:
19559828
11.

The relationship between somatisation and outcome in patients with severe irritable bowel syndrome.

Creed F, Tomenson B, Guthrie E, Ratcliffe J, Fernandes L, Read N, Palmer S, Thompson DG.

J Psychosom Res. 2008 Jun;64(6):613-20. doi: 10.1016/j.jpsychores.2008.02.016.

PMID:
18501262
12.

Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.

Spielmans GI.

Psychother Psychosom. 2008;77(1):12-6. Epub 2007 Dec 14.

PMID:
18087203
13.

Successful treatment of refractory hypochondriasis with duloxetine.

Politi P, Emanuele E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1145-6. Epub 2007 Apr 14. No abstract available.

PMID:
17493731
14.

[Case report of an elderly woman who developed a pain disorder following her husband's death].

Yamamoto K, Onishi Y, Abe T, Kato S.

Seishin Shinkeigaku Zasshi. 2006;108(11):1142-50. Japanese.

PMID:
17313061
15.

Pharmacotherapy of post-traumatic stress disorder.

Opler LA, Grennan MS, Opler MG.

Drugs Today (Barc). 2006 Dec;42(12):803-9. Review.

PMID:
17285153
16.

Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.

Lee SH, Ahn SC, Lee YJ, Choi TK, Yook KH, Suh SY.

J Psychosom Res. 2007 Feb;62(2):189-95.

PMID:
17270577
17.

Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial.

Greeven A, van Balkom AJ, Visser S, Merkelbach JW, van Rood YR, van Dyck R, Van der Does AJ, Zitman FG, Spinhoven P.

Am J Psychiatry. 2007 Jan;164(1):91-9.

PMID:
17202549
18.

A randomized controlled trial of paroxetine for noncardiac chest pain.

Doraiswamy PM, Varia I, Hellegers C, Wagner HR, Clary GL, Beyer JL, Newby LK, O'Connor JF, Beebe KL, O'Connor C, Krishnan KR.

Psychopharmacol Bull. 2006;39(1):15-24.

PMID:
17065971
19.

An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.

Nagata T, van Vliet I, Yamada H, Kataoka K, Iketani T, Kiriike N.

Depress Anxiety. 2006;23(3):168-74.

PMID:
16456863
20.

Antidepressant treatment outcomes of psychogenic movement disorder.

Voon V, Lang AE.

J Clin Psychiatry. 2005 Dec;66(12):1529-34.

PMID:
16401153
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk